Riskpilot← Back to searchSign inGet full accessDoc.Saers AB
ABActiveOrg 5590835806Kvarnvägen 17General medical practice activities · NACE 8621Est. 20160 employees
Revenue 2024
SEK 483K
-38% vs 2023
EBITDA margin
18.6%
-72% vs 2023
Equity ratio
83.1%
Financial strength
Net profit 2024
SEK 153K
-52% vs 2023
| Revenue | SEK 483K | -38% |
| EBITDA | SEK 90K | -72% |
| Net profit | SEK 153K | -52% |
| Total assets | SEK 260K | -54% |
| Equity | SEK 216K | -44% |
| Employees | 0 | — |
Legal name
Doc.Saers AB
Org number
5590835806
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
3 november 2016
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva läkarverksamhet omfattande distriktsläkarvård och övrig hälso- och sjukvård, handla och förvalta aktier, värdepapper, valuta och ädelmetaller och fast egendom. Vidare skall företaget bedriva handel inom optik och optronik och idka därmed förenlig verksamhet.
Address
Kvarnvägen 17
Email
docsaers@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 250 | 577 | 1 078 | 781 | 483 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 70 | 16 | 399 | 322 | 90 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 70 | 16 | 399 | 322 | 90 |
| Net financials | — | — | — | 2 | 2 |
| Profit before tax | 70 | 12 | 301 | 404 | 194 |
| Tax | −15 | −3 | −62 | −85 | −41 |
| Net profit | 55 | 9 | 239 | 319 | 153 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 258 | 261 | 561 | 560 | 260 |
| Equity | 157 | 66 | 305 | 383 | 216 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 22 | 111 | 74 | 75 | 44 |
| Total debt | 22 | 111 | 74 | 75 | 44 |
EBITDA margin
18.6%
This company
15.8%
Market median
+18% vs market
20202024
Equity ratio
83.1%
This company
38.2%
Market median
+118% vs market
20202024
Return on equity
70.8%
This company
18.4%
Market median
+285% vs market
20202024
Net profit margin
31.7%
This company
8.1%
Market median
+291% vs market
20202024
Asset turnover
1.86×
This company
1.12×
Market median
+66% vs market
20202024
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Doc.Saers AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johannes James Saers | Board of Directors | 0 companies |
| Anna Christina Saers | Deputy Board Member | 0 companies |